Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

VEGFB167 Antikörper (FITC)

Der Kaninchen Polyklonal anti-VEGFB167 Antikörper wird verwendet zum Nachweis von VEGFB167 in Proben von Human. Er wurde validiert für WB.
Produktnummer ABIN1388462
-20% for 20 Years of ABO
350,02 €
437,53 €
Sparen Sie 87,51 € (-20 %)
Zzgl. Versandkosten 20,00 € und MwSt
100 μL
Lieferung nach: Deutschland
Lieferung in 20 bis 25 Werktagen

Kurzübersicht für VEGFB167 Antikörper (FITC) (ABIN1388462)

Target

VEGFB167

Reaktivität

Human

Wirt

  • 14
Kaninchen

Klonalität

  • 14
Polyklonal

Konjugat

  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
FITC

Applikation

Western Blotting (WB)
  • Verwendungszweck

    VEGFB167 Polyclonal Antibody, FITC Conjugated

    Kreuzreaktivität

    Ratte

    Homologie

    Human,Mouse,Cow,Pig,Horse,GuineaPig

    Aufreinigung

    Purified by Protein A.

    Immunogen

    KLH conjugated synthetic peptide derived from human VEGFB167

    Isotyp

    IgG
  • Applikationshinweise

    WB(1:300-5000)

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 μg/μL

    Buffer

    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

    Haltbarkeit

    12 months
  • Target

    VEGFB167

    Hintergrund

    Synonyms: VEGFB 167, VEGFB-167, Vascular endothelial growth factor B, VEGF B, VEGFB, VEGF-B, VEGF related factor, VEGFL, Vrf, vascular endothelial growth factor B isoform VEGFB-167 precursor, VEGFB_HUMAN.

    Background: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described and include fibroblast growth factor (FGF), platelet derived growth factor (PDGF) and vascular endothelial growth factors (VEGFs). The VEGF protein family is comprised of VEGF, VEGF-B, VEGF-C and VEGF-D, all of which may exhibit angiogenic function in vivo. VEGF-B, which exists as two alternatively spliced isoforms known as VEGF-B167 and VEGF-B186, is abundantly expressed in heart and skeletal muscle and is frequently co-expressed with VEGF. VEGF-C binds to and specifically activates Flt-4 and Flk-1.

    Gen-ID

    4852

    UniProt

    P49765-2
Sie sind hier:
Chat with us!